Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 45 for “"programmed death-1"”.
-
Programmed death-1 regulates islet-specific lymphocytes in type 1 diabetes
Programmed death-1 (PD-1) is a T cell inhibitory receptor important for tolerance maintenance. PD-1 is highly expressed on chronically stimulated T cells, such as those specific for persistent viral or tumor antigens. PD-1 pathway blockade revolutionized cancer therapy in recent years. While …
-
Combining Vitamin D with Programmed Death 1 Blockade in Head and Neck Cancer
Antibodies that block the interaction between programmed cell death protein 1 (PD-1) and its ligand (PD-L1) have received regulatory approval for the treatment of patients with advanced head and neck squamous cell carcinoma (HNSCC). These antibodies (α-PD1) have led to remarkable outcomes in this …
-
Expression of programmed death-1 (PD-1) and PD-1 ligands in rheumatoid arthritis, in human and murine tissue, and their role in immunological tolerance
… are crucial for fine-tuning of T cell function.Programmed death-1 (PD-1) is an inhibitory lymphocyte receptor that has recently emerged as a key playerin induction and maintenance of tolerance.Rheumatoid arthritis (RA) is a chronic inflammatory disease of joints and extra-articular tissues, …
-
Expression of programmed death-1 (PD-1) and PD-1 ligands in human and murine tissue and their role in immunological tolerance: genetic, immunologic and immunohistochemical analysis of the PD-1/PD-L1 pathway in human systemic lupus erythematosus
… are crucial for fine-tuning of T cell function. Programmed death-1 (PD-1) is an inhibitory lymphocyte receptor that has recently emerged as a key player in induction and maintenance of tolerance. Compared to other B7 receptors, PD-1 has a broader role in regulation of immune responses considering …
-
Delineation of novel immunoregulatory mechanisms in autoimmune diseases: the role of plasmacytoid dendritic cells in the initiation of autoimmune response
… autoimmune milieu led to up-regulation of the programmed death 1 ligand (PD LI) that was required for the G-MDSC-mediated suppressive function both in vitro and in vivo Importantly, MDSCs were enriched in the periphery of subjects with active multiple sclerosis (MS) and suppressed the …
-
Interaction Between Immunosuppressive and Cholinergic Markers in Colorectal Cancer
… of immune checkpoints inhibitors such as programmed death 1 (PD-1), PD-L1, programmed death ligand 1 and 2 (PD-L1, PD- L2), sialic acid-binding lectins 9 (siglec-9) and IDO (indoleamine-2,3-dioxygenase). These molecules function by inhibiting anti-tumour effects of T cell-mediated immune …
-
TGF-BETA1/SMAD3 SUPPRESS ANTI-TUMOR IMMUNITY BY ENHANCING PD-1 EXPRESSION ON ANTIGEN-SPECIFIC CD8+ T CELLS IN CANCER
Programmed Death-1 (PD-1) is a co-inhibitory receptor that is highly expressed on exhausted tumor-infiltrating lymphocytes (TILs) in cancers and on virus-specific T cells in chronic HBV, HIV and HCV infection. Signaling through PD-1 inhibits T cell effecter function and limits effective anti-tumor …
-
The Integrated Stress Response Pathway Regulates PD-L1 Translation in Human Lung Cancer
… human lung cancer cells express high levels of Programmed Death Ligand 1 (PD-L1), a ligand of the Programmed Death 1 (PD-1) receptor on T-cells, which allows them to directly suppress T-cell proliferation and function. Monoclonal antibodies disrupting this pathway have yielded remarkable …
-
An investigation into the impact of cytomegalovirus infection in patients with chronic lymphocytic leukaemia
… with infection being the predominant cause of death. The immunosuppression is multifactorial and includes hypogammaglobulinaemia and T cell dysfunction. Expanded populations of effector memory T cells which are oligoclonal are postulated to arise in response to common antigenic stimulation. …
-
THE IMMUNOLOGICAL EFFECTS OF CHECKPOINT BLOCKADE IN COMBINATION WITH A TYROSINE KINASE INHIBITOR IN A MURINE MODEL OF RENAL CELL CARCINOMA
… (RCC) is responsible for approximately 13,500 deaths in the US each year and 65,000 new cases are diagnosed here annually. Despite the approval of multiple new drugs targeting mTOR and angiogenic pathways, there is still no curative treatment. Only 20-30% of patients respond to these targeted …
-
Detection of genomic rearrangements in archival lymphoma tissues using targeted capture sequencing
… the MHC class II transactivator CIITA and the programmed death 1 ligands PDL1 and PDL2 have been shown to contribute to an immune privilege phenotype in multiple B-cell lymphomas, with implications for novel therapeutic approaches. However, the landscape of fusion partners for these genes has …
-
The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer
… immune response. The interaction of the Programmed Death Ligand 1 (PD-L1) on the surface of tumour cells with the Programmed Death-1 (PD-1) receptor on cytotoxic T lymphocytes leads to inactivation of these immune effectors, and is a specific example of an immune escape mechanism tumour …
-
The inhibitory receptor PD-1 differentially regulates effector and anergic autoreactive CD4 T cells during Type 1 Diabetes
… on one critical inhibitory pathway involving Programmed-Death 1 (PD-1). Using these models, we showed that in diabetes-susceptible NOD mice, the majority of islet-reactive CD4 T cells become activated, but the pathogenic subset capable of contributing to disease was relatively small. Rather, …
-
Immunology of Granulomatosis with Polyangiitis
… cells expressing the immune suppressor molecules programmed death 1 (PD-1) and its ligands in GPA. In mucosa from GPA patients, activated B cells were observed located alongside PR3 expressing cells and B cell survival factors BAFF and APRIL, which was produced by the granulomas and giant cells. B …
-
Ανοσοθεραπεία στον καρκίνο του πνεύμονα: οι τοξικότητες και η διαχείριση τους
… Τ λεμφοκυττάρων) και εκείνο του υποδοχέα PD-1 (programmed death 1, μόριο προγραμματισμένου κυτταρικού θανάτου-1). Η πρόσδεση μορίων αγωνιστών στους συνδιεγερτικούς υποδοχείς ή μορίων ανταγωνιστών των ανασταλτικών σημάτων έχει ως αποτέλεσμα την ενίσχυση της απόκρισης των Τ κυττάρων και την …
-
Characterizing the Development of T cell Exhaustion Independent of PD-1
… to the decreased function of these cells. Programmed death-1 (PD-1), T cell immunoglobulin mucin-3 (TIM-3), cytotoxic T lymphocyte associated protein 4 (CTLA-4), and several other molecules have important functions in driving and maintaining T cell exhaustion. Research has furthered our …
-
Inhibitors of the PD1/PD-L1 interaction: missteps, mechanisms and mysteries
… by the immune system is by expressing programmed death ligand 1 (PD-L1). PD-L1 binds to its receptor programmed death 1 (PD1) on T cells, inhibiting T cell responsiveness to antigenic stimuli. Blockade of the PD1/PD-L1 pathway removes this negative signal and restores anti-tumour …
-
Novel Imaging-Based Techniques Reveal A Role For Pd-1/Pd-L1 In Tumor Immune Surveillance In The Lung
The binding of immune inhibitory receptor Programmed Death 1 (PD-1) on T cells to its ligand PD-L1 has been implicated as a major contributor to tumor induced immune suppression. Clinical trials of PD-L1 blockade have proven effective in unleashing therapeutic anti-tumor immune responses in a …
-
Microfluidic Biopsy Trapping Device for the Real-time Monitoring of the Tumor Microenvironment
… staurosporine, was used to assess tumor cell death as a proof of principle. Lastly, we tested the model for its ability to demonstrate similar results found in clinic when using a Wee1 inhibitor on osteosarcoma and an epidermal growth factor receptor inhibitor, Erlotinib, and inhibitors of …
-
Exploring the relationship and distribution of PD-1 and TCR/CD28 in T cells using a Super-Resolution approach
… 28 (CD28) which enhances T cell activation and Programmed death- 1 (PD-1), which inhibits T-cell activation. When PD-1 is bound to its ligands PD-L1 or PD-L2, it transduces an inhibitory signal marked by SHP2 phosphatase recruitment, that blocks the signalling cascade of TCR or CD28. Under …
Page 1 of 3